Principles for Artificial Intelligence in Medical Technology
This document provides the medical device industry’s foundational principles for artificial intelligence in medical technology. These principles will guide further innovations, policymaking, and regulations in AI-enabled medical technology.
Related Reading
Event / Regulatory Affairs
False Claims Act Risks and Enforcement Priorities for the Med Tech Industry
October 7, 2026
12:00 PM – 1:00 PM
Join Akin Gump as they provide actionable takeaways to minimize compliance risks and position organizations for effective and credible responses when FCA investigations arise.
News / Government & Legislative Affairs / Regulatory Affairs / Small Business
AdvaMed Names Juan Carlos “JC” Scott Chief Strategy Officer and Executive Director of AdvaMed Accel
August 12, 2026
WASHINGTON, D.C. – AdvaMed today announced that Juan Carlos “JC” Scott has been appointed Chief Strategy Officer and Executive Director of AdvaMed Accel, a newly created leadership position focused on accelerating engagement with emerging medical technology companies and strengthening AdvaMed’s role at the center of the innovation ecosystem.
Resource / Coverage & Payment / Regulatory Affairs
AdvaMed® Comments on FDA-2016-D-1307 Communications with Payors
August 7, 2026
AdvaMed’s recent submission to the Food and Drug Administration (FDA) provides comments on the Agency’s revised draft guidance governing communications between drug and device manufacturers and payors, formulary committees, and similar entities.
Event / AdvaMed Advancements / Business Development / Government & Legislative Affairs / Regulatory Affairs / Small Business
AdvaMed® Medtech Showcase
September 16, 2026
5:00 PM – 7:00 PM
Experience the future of health care at the 2026 Medtech Showcase and Reception on Capitol Hill. Join AdvaMed® on September 16 for an interactive event featuring more than 25 medtech companies demonstrating breakthrough technologies that are transforming patient care. See innovative medical devices firsthand, connect with industry leaders and policymakers, and discover how medtech innovation is improving and saving lives.
News / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Strongly Supports Draft MDUFA VI Agreement at FDA Public Meeting
August 5, 2026
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today expressed strong support for the draft Medical Device User Fee Amendments (MDUFA) VI agreement at an FDA public hearing.
Event / Regulatory Affairs
From Launch to Exit: Leveraging IP to Build and Protect Enterprise Value
October 6, 2026
1:00 PM – 2:00 PM
Join Cooley LLP as they explore how to evaluate and strengthen your IP position, prepare for competitive challenges, and avoid common pitfalls that can undermine value during due diligence and transactions.
Event / Global & Trade / Regulatory Affairs
Entering the Japanese Medical Device Market: Regulatory Pathways, Consultation Opportunities, and Practical Insights
September 1, 2026 |
7:00 PM – 8:30 PM ET
September 2, 2026 |
8:00 AM – 9:30 AM JST
Learn how to enter Japan’s medtech market with insights on regulatory pathways, consultation services, and practical insights for U.S. medtech companies.
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
July 27, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Jacque Engle, Vice President of Marketing & Communication and Juli Goldstein, Vice President of Government Affairs & Market Access at Digital Diagnostics.